| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.27e-06 | 5 | 139 | 3 | GO:0030156 | |
| MousePheno | ectopic manchette | 1.58e-05 | 19 | 116 | 4 | MP:0009377 | |
| MousePheno | abnormal manchette morphology | 3.38e-05 | 45 | 116 | 5 | MP:0009376 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STIM2 UBAP2 KIF1B IQSEC2 HJURP IRS1 FRYL SRGAP2 CBX4 RASSF7 RUSC2 MLXIPL AKAP9 MTUS1 SSX2IP NEURL1 KMT2A CRTC2 MAP3K2 | 3.71e-09 | 861 | 145 | 19 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 FOXK2 RHBDF1 IRS1 FRYL SRGAP2 TNFRSF21 ABCA7 RASSF7 KCNH3 PKMYT1 STK10 NFATC1 INF2 ZNF592 SETD5 BTBD7 GLI1 OSBPL5 DEPDC5 RAB11FIP3 | 7.23e-09 | 1105 | 145 | 21 | 35748872 |
| Pubmed | USP36 GTPBP4 IL16 ERF ASCC1 CBX4 PPFIA3 PLEKHN1 ABCA7 DNAJA3 SF3B3 FBXO5 MTUS1 ZNF592 SETD5 NAF1 SSX2IP NEURL1 SIGLEC1 SP140 | 4.47e-08 | 1116 | 145 | 20 | 31753913 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX4 CUX2 TCF7L2 FOXK2 ERF GATA6 HIF3A CREBZF MLXIPL KLF16 OTX2 NFATC1 GLI1 BARHL1 BHLHE22 KMT2A MESP2 TBX20 | 5.02e-08 | 908 | 145 | 18 | 19274049 |
| Pubmed | SOX4 NR2E3 CUX2 TCF7L2 FOXK2 ERF KIF1B GATA6 DIDO1 HIF3A OTX2 GLI1 BARHL1 KMT2A TACC3 CNOT2 | 5.09e-08 | 709 | 145 | 16 | 22988430 | |
| Pubmed | 2.52e-07 | 151 | 145 | 8 | 17043677 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.83e-07 | 4 | 145 | 3 | 19091768 | |
| Pubmed | SOX4 NR2E3 CUX2 TCF7L2 ERF GATA6 DIDO1 KLF16 OTX2 NFATC1 ZNF592 BTBD7 GLIS2 MESP2 TBX20 CNOT2 | 2.97e-07 | 808 | 145 | 16 | 20412781 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXK2 ERF IQSEC2 ASCC1 SAPCD2 RASSF7 RUSC2 STK10 MLXIPL HROB AAAS BTBD7 NAF1 SSX2IP TNKS CNOT2 FAM83A CRTC2 | 3.61e-07 | 1038 | 145 | 18 | 26673895 |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 7.05e-07 | 5 | 145 | 3 | 17855024 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CUX2 TCF7L2 UBAP2 DISC1 INPP5D HJURP STK10 CBFA2T2 STON2 TNKS CRTC2 | 2.09e-06 | 430 | 145 | 11 | 35044719 |
| Pubmed | GTPBP4 UBAP2 DSCAM CENPF IQSEC2 DIDO1 SRGAP2 PPFIA3 CLIP1 AKAP9 KCTD16 STON2 FBXO41 TNKS TACC3 AGAP2 | 2.91e-06 | 963 | 145 | 16 | 28671696 | |
| Pubmed | 4.85e-06 | 103 | 145 | 6 | 10819331 | ||
| Pubmed | SOX4 NR2E3 TCF7L2 HJURP FRYL CREBZF PKMYT1 PRKD3 OTX2 NFATC1 MTUS1 GLIS2 BHLHE22 KMT2A GREB1 SAMD14 | 5.06e-06 | 1006 | 145 | 16 | 15226823 | |
| Pubmed | 1.26e-05 | 255 | 145 | 8 | 15324660 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 26601952 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12015314 | ||
| Pubmed | Absence of major histocompatibility class II expression does not impair hematopoiesis in mice. | 1.73e-05 | 2 | 145 | 2 | 11532347 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 17854671 | ||
| Pubmed | PRKD3 promotes malignant progression of OSCC by downregulating KLF16 expression. | 1.73e-05 | 2 | 145 | 2 | 33378018 | |
| Pubmed | AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner. | 1.73e-05 | 2 | 145 | 2 | 16061630 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25926640 | ||
| Pubmed | Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. | 1.73e-05 | 2 | 145 | 2 | 11889139 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 15003449 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 23233134 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SOX4 CUX2 GATA6 KLF16 OTX2 NFATC1 BARHL1 GLIS2 BHLHE22 MESP2 TBX20 | 1.90e-05 | 544 | 145 | 11 | 28473536 |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 2.50e-05 | 14 | 145 | 3 | 17662146 | |
| Pubmed | 2.52e-05 | 281 | 145 | 8 | 24163370 | ||
| Pubmed | IL16 FOXK2 RNPC3 IQSEC2 SRGAP2 STK10 AKAP9 NFATC1 INF2 NAF1 SSX2IP RIMBP3C | 3.42e-05 | 689 | 145 | 12 | 36543142 | |
| Pubmed | Identification and characterization of VPO1, a new animal heme-containing peroxidase. | 3.82e-05 | 16 | 145 | 3 | 18929642 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TCF7L2 FOXK2 KIF1B FRYL SRGAP2 PPM1K TECTA SELENON BICD1 STK10 NFATC1 INF2 SETD5 CBFA2T2 SEMA3B OSBPL5 GREB1 VPS13B | 5.07e-05 | 1489 | 145 | 18 | 28611215 |
| Pubmed | Hedgehog signaling indirectly affects tubular cell survival after obstructive kidney injury. | 5.16e-05 | 3 | 145 | 2 | 26290370 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 21816948 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 30419905 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 23401856 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 28063190 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 22231735 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 29459676 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 31541015 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 18195096 | ||
| Pubmed | 8.93e-05 | 21 | 145 | 3 | 22932696 | ||
| Pubmed | A critical role for the EphA3 receptor tyrosine kinase in heart development. | 1.03e-04 | 4 | 145 | 2 | 17046737 | |
| Pubmed | MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function. | 1.03e-04 | 4 | 145 | 2 | 29662197 | |
| Pubmed | Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade. | 1.03e-04 | 4 | 145 | 2 | 22131333 | |
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 21353197 | ||
| Pubmed | 1.03e-04 | 4 | 145 | 2 | 30567484 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 GTPBP4 TCF7L2 FOXK2 ERF CENPF GATA6 DIDO1 CBX4 DNAJA3 MLXIPL KLF16 AAAS SF3B3 RBMX2 KMT2A | 1.05e-04 | 1294 | 145 | 16 | 30804502 |
| Pubmed | 1.13e-04 | 446 | 145 | 9 | 24255178 | ||
| Pubmed | 1.18e-04 | 23 | 145 | 3 | 20875817 | ||
| Pubmed | Cyclin D1 fine-tunes the neurogenic output of embryonic retinal progenitor cells. | 1.35e-04 | 24 | 145 | 3 | 19416500 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.52e-04 | 120 | 145 | 5 | 31413325 | |
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 25625206 | ||
| Pubmed | Store-Operated Ca2+ Entry Controls Clonal Expansion of T Cells through Metabolic Reprogramming. | 1.71e-04 | 5 | 145 | 2 | 29030115 | |
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 20540670 | ||
| Pubmed | Ripply2 is essential for precise somite formation during mouse early development. | 1.71e-04 | 5 | 145 | 2 | 17531978 | |
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 20437825 | ||
| Pubmed | Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. | 1.71e-04 | 5 | 145 | 2 | 9515963 | |
| Pubmed | IRS pleckstrin homology domains bind to acidic motifs in proteins. | 1.71e-04 | 5 | 145 | 2 | 9813005 | |
| Pubmed | 1.71e-04 | 5 | 145 | 2 | 18039847 | ||
| Pubmed | 1.93e-04 | 27 | 145 | 3 | 23824573 | ||
| Pubmed | 2.15e-04 | 28 | 145 | 3 | 38344749 | ||
| Pubmed | 2.52e-04 | 497 | 145 | 9 | 23414517 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 19318350 | ||
| Pubmed | Dmbx1 is a paired-box containing gene specifically expressed in the caudal most brain structures. | 2.56e-04 | 6 | 145 | 2 | 12175515 | |
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 21659360 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 12829790 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 21542136 | ||
| Pubmed | 2.56e-04 | 6 | 145 | 2 | 30910863 | ||
| Pubmed | 2.61e-04 | 210 | 145 | 6 | 16565220 | ||
| Pubmed | 2.75e-04 | 503 | 145 | 9 | 16964243 | ||
| Pubmed | Sf3b4 regulates chromatin remodeler splicing and Hox expression. | 3.22e-04 | 32 | 145 | 3 | 37167859 | |
| Pubmed | 3.22e-04 | 32 | 145 | 3 | 19805139 | ||
| Pubmed | 3.58e-04 | 7 | 145 | 2 | 23499491 | ||
| Pubmed | Gata4 regulates hedgehog signaling and Gata6 expression for outflow tract development. | 3.58e-04 | 7 | 145 | 2 | 31120883 | |
| Pubmed | 3.58e-04 | 7 | 145 | 2 | 16059920 | ||
| Pubmed | 3.58e-04 | 7 | 145 | 2 | 17875931 | ||
| Pubmed | 3.58e-04 | 7 | 145 | 2 | 23756994 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 3.78e-04 | 146 | 145 | 5 | 20686565 | |
| Pubmed | 3.96e-04 | 227 | 145 | 6 | 26410627 | ||
| Pubmed | 3.97e-04 | 529 | 145 | 9 | 14621295 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 KIF1B DIDO1 CLIP1 STK10 ZNF592 RBMX2 CBFA2T2 NAF1 KMT2A TACC3 | 4.21e-04 | 774 | 145 | 11 | 15302935 |
| Pubmed | SOX4 SAPCD2 PKMYT1 MLXIPL KLF16 KLLN AAAS OTX2 SF3B3 FBXO5 BTBD7 KMT2A DEPDC5 CNOT2 RAB11FIP3 | 4.51e-04 | 1327 | 145 | 15 | 32694731 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 4.75e-04 | 8 | 145 | 2 | 21165971 | |
| Pubmed | A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. | 4.75e-04 | 8 | 145 | 2 | 10888889 | |
| Pubmed | 4.75e-04 | 8 | 145 | 2 | 22031837 | ||
| Pubmed | 4.75e-04 | 8 | 145 | 2 | 19734900 | ||
| Pubmed | Divergent hTAFII31-binding motifs hidden in activation domains. | 4.75e-04 | 8 | 145 | 2 | 10821850 | |
| Pubmed | Stage-dependent requirement of neuroretinal Pax6 for lens and retina development. | 5.81e-04 | 39 | 145 | 3 | 24523460 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.96e-04 | 341 | 145 | 7 | 32971831 | |
| Pubmed | 6.10e-04 | 9 | 145 | 2 | 26653852 | ||
| Pubmed | 6.10e-04 | 9 | 145 | 2 | 17395647 | ||
| Pubmed | Genetic chimeras reveal the autonomy requirements for Vsx2 in embryonic retinal progenitor cells. | 6.10e-04 | 9 | 145 | 2 | 25927996 | |
| Pubmed | GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. | 6.10e-04 | 9 | 145 | 2 | 9832509 | |
| Pubmed | Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. | 6.10e-04 | 9 | 145 | 2 | 22284184 | |
| Pubmed | 6.26e-04 | 40 | 145 | 3 | 26297811 | ||
| Pubmed | FOXK2 RHBDF1 HJURP GATA6 DIDO1 FRYL SRGAP2 INF2 SETD5 GLI1 CNOT2 VPS13B RAB11FIP3 | 6.36e-04 | 1084 | 145 | 13 | 11544199 | |
| Pubmed | 6.71e-04 | 251 | 145 | 6 | 29031500 | ||
| Pubmed | Probing chromatin landscape reveals roles of endocardial TBX20 in septation. | 7.60e-04 | 10 | 145 | 2 | 27348591 | |
| Pubmed | CD spectra show the relational style between Zic-, Gli-, Glis-zinc finger protein and DNA. | 7.60e-04 | 10 | 145 | 2 | 18298960 | |
| Pubmed | 7.60e-04 | 10 | 145 | 2 | 24942581 | ||
| Interaction | TOP3B interactions | SOX4 FOXK2 UBAP2 RHBDF1 CENPF KIF1B IRS1 FRYL SRGAP2 TNFRSF21 ABCA7 RASSF7 KCNH3 PKMYT1 STK10 NFATC1 INF2 ZNF592 SETD5 BTBD7 GLI1 RBMX2 SSX2IP OSBPL5 DEPDC5 CNOT2 RAB11FIP3 | 3.69e-06 | 1470 | 142 | 27 | int:TOP3B |
| Interaction | TENT5B interactions | 9.16e-06 | 69 | 142 | 6 | int:TENT5B | |
| Cytoband | 16p13.3 | 1.33e-04 | 244 | 145 | 6 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 4.34e-04 | 426 | 145 | 7 | chr16p13 | |
| GeneFamily | Cadherin related | 8.50e-05 | 17 | 93 | 3 | 24 | |
| GeneFamily | Sterile alpha motif domain containing | 9.04e-05 | 88 | 93 | 5 | 760 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.81e-04 | 206 | 93 | 6 | 682 | |
| GeneFamily | Cyclins|F-boxes other | 1.05e-03 | 39 | 93 | 3 | 560 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.50e-03 | 110 | 93 | 4 | 420 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-08 | 195 | 145 | 9 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-07 | 174 | 145 | 8 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-07 | 197 | 145 | 8 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-07 | 197 | 145 | 8 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 200 | 145 | 8 | 4c22a1f35ff496fa6af2ab171f2936785272bc06 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Stem_cells-Neuroepithelial_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 200 | 145 | 8 | 0632b8d3a1be437f146bc86aae9646303e37a0bd | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-06 | 164 | 145 | 7 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 169 | 145 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-06 | 171 | 145 | 7 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 172 | 145 | 7 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 174 | 145 | 7 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-06 | 174 | 145 | 7 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-06 | 174 | 145 | 7 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.12e-06 | 64 | 145 | 5 | bf923a66b17e717b8d3817b9d0e201b82a7e4a88 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.12e-06 | 64 | 145 | 5 | a3e852600c53b11175eb579e92962fa711f5678b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.12e-06 | 64 | 145 | 5 | f8f43ad9354c786b418bac54614f96f50e8bea68 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-06 | 183 | 145 | 7 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 2.54e-06 | 185 | 145 | 7 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-06 | 187 | 145 | 7 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.82e-06 | 188 | 145 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-06 | 190 | 145 | 7 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-06 | 190 | 145 | 7 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.13e-06 | 191 | 145 | 7 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Cycling_DC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 191 | 145 | 7 | 1da569ebcfab4e1a95315430ae77a17a1f119263 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-06 | 192 | 145 | 7 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-06 | 193 | 145 | 7 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-06 | 193 | 145 | 7 | 444de545117dae8ab24a22880583ac2f0b2d6eac | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.47e-06 | 194 | 145 | 7 | 7c38ead538695db1fb1c329ff67d2874aa83c8d2 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic-platelet|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.47e-06 | 194 | 145 | 7 | 4531639974e363a6ff7ea688325a11407c3efd87 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-06 | 195 | 145 | 7 | 2d485373bfd9bb4bb9236bf0b31d03e132c8018f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 3.59e-06 | 195 | 145 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-06 | 195 | 145 | 7 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | Healthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.84e-06 | 197 | 145 | 7 | 3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.97e-06 | 198 | 145 | 7 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 3.97e-06 | 198 | 145 | 7 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.97e-06 | 198 | 145 | 7 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.11e-06 | 199 | 145 | 7 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.11e-06 | 199 | 145 | 7 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-06 | 200 | 145 | 7 | 02594c1edbc9f2cf831639cd83363abd2551cb94 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-06 | 200 | 145 | 7 | 46521d83b917b0357601db8783c8da6b73730d60 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 159 | 145 | 6 | 0fbfdb18b7ed4bde077add13f2b3636e144b254f | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 164 | 145 | 6 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-05 | 166 | 145 | 6 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.75e-05 | 166 | 145 | 6 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 167 | 145 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 169 | 145 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-05 | 171 | 145 | 6 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-05 | 171 | 145 | 6 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 171 | 145 | 6 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-05 | 171 | 145 | 6 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 172 | 145 | 6 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-05 | 175 | 145 | 6 | baaffc9af61f12168d6f7b96eb0b6e98a44a3909 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 176 | 145 | 6 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 177 | 145 | 6 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 177 | 145 | 6 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 178 | 145 | 6 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 179 | 145 | 6 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 2.68e-05 | 179 | 145 | 6 | 7d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.77e-05 | 180 | 145 | 6 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 180 | 145 | 6 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 181 | 145 | 6 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 181 | 145 | 6 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 181 | 145 | 6 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 181 | 145 | 6 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 183 | 145 | 6 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 3.13e-05 | 184 | 145 | 6 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.23e-05 | 185 | 145 | 6 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 185 | 145 | 6 | 736bf89a7a1a840ab6920060f2d98598332065a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-05 | 187 | 145 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.53e-05 | 188 | 145 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.64e-05 | 189 | 145 | 6 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 191 | 145 | 6 | ff2cc4c10aa584b3daeaaf23cd8ee09bdbdf684d | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.86e-05 | 191 | 145 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.86e-05 | 191 | 145 | 6 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 192 | 145 | 6 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.97e-05 | 192 | 145 | 6 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 192 | 145 | 6 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-05 | 193 | 145 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 4.09e-05 | 193 | 145 | 6 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 193 | 145 | 6 | e7b2d99342e3eb4a05d298c2f124dd20bed8a743 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.09e-05 | 193 | 145 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 193 | 145 | 6 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.21e-05 | 194 | 145 | 6 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.21e-05 | 194 | 145 | 6 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.21e-05 | 194 | 145 | 6 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 194 | 145 | 6 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-05 | 194 | 145 | 6 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 194 | 145 | 6 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 194 | 145 | 6 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 194 | 145 | 6 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.33e-05 | 195 | 145 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.33e-05 | 195 | 145 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.33e-05 | 195 | 145 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-05 | 195 | 145 | 6 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 195 | 145 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 195 | 145 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | CENPF DISC1 PPFIA3 BICD1 MLXIPL HROB MTUS1 CBFA2T2 MAP3K2 RAB11FIP3 | 3.97e-07 | 198 | 139 | 10 | 6426_DN |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 3.24e-06 | 195 | 139 | 9 | 667_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.52e-06 | 197 | 139 | 9 | 7227_DN | |
| Drug | staurosporine; Down 200; 0.1uM; MCF7; HG-U133A | 1.79e-05 | 184 | 139 | 8 | 423_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 1.86e-05 | 185 | 139 | 8 | 5439_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 190 | 139 | 8 | 6274_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.71e-05 | 195 | 139 | 8 | 1522_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.71e-05 | 195 | 139 | 8 | 2761_DN | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A | 2.71e-05 | 195 | 139 | 8 | 1420_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 3255_DN | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 2491_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 4477_DN | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; HL60; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 2401_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 2070_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 3622_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.02e-05 | 198 | 139 | 8 | 7384_DN | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; PC3; HT_HG-U133A | 3.02e-05 | 198 | 139 | 8 | 5117_UP | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; HL60; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 1862_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 2769_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 3.25e-05 | 200 | 139 | 8 | 3097_DN | |
| Drug | Polychlorinated Biphenyls | SOX4 CENPF DIDO1 PPM1K KRT80 FBXO5 SETD5 NAF1 KCTD16 GREB1 TACC3 SPOCD1 CXCL5 SP140 | 3.43e-05 | 633 | 139 | 14 | ctd:D011078 |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.10e-04 | 177 | 139 | 7 | 841_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.31e-04 | 182 | 139 | 7 | 3887_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.44e-04 | 185 | 139 | 7 | 1114_DN | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 1.54e-04 | 187 | 139 | 7 | 3075_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.54e-04 | 187 | 139 | 7 | 7080_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 189 | 139 | 7 | 5248_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 1.70e-04 | 190 | 139 | 7 | 7070_UP | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A | 1.82e-04 | 192 | 139 | 7 | 6162_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 3258_DN | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 3229_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 2412_UP | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 5985_DN | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 2427_DN | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; HL60; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 1264_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 3969_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 6178_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 7044_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 1.94e-04 | 194 | 139 | 7 | 1715_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 7098_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 4001_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.00e-04 | 195 | 139 | 7 | 999_DN | |
| Drug | 5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA | 2.00e-04 | 195 | 139 | 7 | 843_DN | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 2411_UP | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 3457_DN | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A | 2.00e-04 | 195 | 139 | 7 | 573_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 6648_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 4495_DN | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; PC3; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 7527_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5569_DN | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 7029_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5088_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 2889_DN | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 6396_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; HL60; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3099_DN | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3431_UP | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 7386_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 6776_DN | |
| Drug | U0125; Down 200; 1uM; PC3; HG-U133A | 2.13e-04 | 197 | 139 | 7 | 663_DN | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 4127_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 1463_DN | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 6781_DN | |
| Drug | tamoxifen citrate; Down 200; 1uM; ssMCF7; HG-U133A | 2.13e-04 | 197 | 139 | 7 | 375_DN | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 4963_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 6197_UP | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 3259_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; HL60; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 2352_DN | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 2170_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 3326_DN | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 6501_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 5793_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 3793_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 6001_DN | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.19e-04 | 198 | 139 | 7 | 440_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 7135_DN | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5085_UP | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 2862_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 3274_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 2618_DN | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 2.26e-04 | 199 | 139 | 7 | 314_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 1484_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5949_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; HL60; HG-U133A | 2.26e-04 | 199 | 139 | 7 | 1403_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5844_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5843_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 1493_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.33e-04 | 200 | 139 | 7 | 417_DN | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; HL60; HG-U133A | 2.33e-04 | 200 | 139 | 7 | 1980_UP | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 2.33e-04 | 200 | 139 | 7 | 2759_DN | |
| Drug | cobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A | 2.33e-04 | 200 | 139 | 7 | 379_DN | |
| Drug | lyso-PAF C18 | 2.66e-04 | 51 | 139 | 4 | CID000003855 | |
| Disease | Liver carcinoma | CENPF HJURP IRS1 CD163 PKMYT1 MLXIPL MTUS1 GLI1 KMT2A DEPDC5 TACC3 | 2.28e-05 | 507 | 135 | 11 | C2239176 |
| Disease | ventricular septal defect (is_implicated_in) | 3.29e-05 | 14 | 135 | 3 | DOID:1657 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 7.00e-05 | 93 | 135 | 5 | C1535926 | |
| Disease | neuroimaging measurement | DCHS2 TCF7L2 FBXL19-AS1 UBAP2 C16orf95 KIF1B FRYL BICD1 DNAJA3 MLXIPL CCM2 CBFA2T2 GLIS2 TACC3 CRTC2 | 1.18e-04 | 1069 | 135 | 15 | EFO_0004346 |
| Disease | congenital heart disease (is_implicated_in) | 1.77e-04 | 24 | 135 | 3 | DOID:1682 (is_implicated_in) | |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 3.08e-04 | 6 | 135 | 2 | EFO_0021231 | |
| Disease | panhypopituitarism (is_implicated_in) | 4.30e-04 | 7 | 135 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | sexual dimorphism measurement | USP36 FRYL CLIP1 STK10 MLXIPL HROB ZNF592 SCMH1 CBFA2T2 CARD11 TNKS TACC3 SPOCD1 AGAP2 | 5.62e-04 | 1106 | 135 | 14 | EFO_0021796 |
| Disease | Cornelia De Lange Syndrome | 5.71e-04 | 8 | 135 | 2 | C0270972 | |
| Disease | Ostium secundum atrial septal defect | 7.32e-04 | 9 | 135 | 2 | C0344724 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 9.13e-04 | 10 | 135 | 2 | EFO_0021020 | |
| Disease | reticulocyte measurement | FOXK2 UBAP2 VWF INPP5D IRS1 CLIP1 DNAJA3 MLXIPL KLF16 CCM2 DEPDC5 SIGLEC1 SPOCD1 | 1.12e-03 | 1053 | 135 | 13 | EFO_0010700 |
| Disease | 3-hydroxypropylmercapturic acid measurement | 1.22e-03 | 352 | 135 | 7 | EFO_0007014 | |
| Disease | sodium measurement | 1.31e-03 | 103 | 135 | 4 | EFO_0009282 | |
| Disease | tetralogy of Fallot (is_implicated_in) | 1.57e-03 | 13 | 135 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | white matter microstructure measurement | 2.18e-03 | 390 | 135 | 7 | EFO_0005674 | |
| Disease | age at first birth measurement | 2.28e-03 | 120 | 135 | 4 | EFO_0009101 | |
| Disease | gastroparesis | 2.39e-03 | 16 | 135 | 2 | EFO_1000948 | |
| Disease | cutaneous Leishmaniasis | 2.39e-03 | 16 | 135 | 2 | EFO_0005046 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 2.65e-03 | 60 | 135 | 3 | EFO_0020690 | |
| Disease | reticulocyte count | TCF7L2 FOXK2 UBAP2 VWF INPP5D IRS1 CLIP1 MLXIPL KLF16 CCM2 DEPDC5 SPOCD1 | 3.13e-03 | 1045 | 135 | 12 | EFO_0007986 |
| Disease | obesity (implicated_via_orthology) | 3.16e-03 | 215 | 135 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.74e-03 | 20 | 135 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.94e-03 | 69 | 135 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Left Ventricle Remodeling | 4.12e-03 | 21 | 135 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 4.12e-03 | 21 | 135 | 2 | C0600519 | |
| Disease | bilirubin measurement | 4.33e-03 | 442 | 135 | 7 | EFO_0004570 | |
| Disease | p-tau measurement | 4.44e-03 | 72 | 135 | 3 | EFO_0004763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDSFNIPGSSCSLLS | 741 | Q8NDL9 | |
| SAPAFSPISCSLSDS | 841 | Q8NDL9 | |
| TEDPRSPPACSSSSS | 156 | P50548 | |
| TLDPTSLSTRPSSGC | 221 | Q9NRG9 | |
| EPSLVSPSTSCGSLT | 3571 | Q99996 | |
| CSSDSPPRPSSCLLT | 246 | Q9N2J8 | |
| PSLCDQSRPRTSGAS | 861 | Q96G01 | |
| PFSSSSLSCLNLPEG | 211 | P33076 | |
| SLPASPSTSDFCQTR | 536 | Q9Y2D8 | |
| RERPASSSSSPLGCF | 51 | Q8NFJ8 | |
| EDSAPPSSVARSGSC | 556 | Q9BZE4 | |
| VCSDAGSPEPLSSST | 2436 | Q6V0I7 | |
| GLRTSSLSHSACPTP | 4681 | Q6V0I7 | |
| RSESSSDCSSPASPG | 41 | Q9BZE3 | |
| ALSTDCTPSGDLSPL | 806 | Q99490 | |
| NLCLPGSSDSPASAS | 366 | Q8N9N2 | |
| PGISPSQSLCAESSR | 161 | Q9BSQ5 | |
| SCLSFSLPASPTDSG | 56 | P56555 | |
| GSDSESPATRSECPS | 1141 | O14529 | |
| SLPSAELSSNSCSPG | 176 | Q9NRI5 | |
| SALPDSSLSPACSEL | 256 | Q8IZY2 | |
| AGRCLPKSDSSSSLP | 511 | Q8NCD3 | |
| RTGPSLAGRPSSDSC | 86 | Q02833 | |
| STSEPRCSRFDPDGS | 41 | Q8N3J5 | |
| SSPYSSSSPCGLDSI | 206 | Q9Y5X4 | |
| CGARTPSPSLSESSE | 136 | Q9Y388 | |
| RSLGLVSSACSSSPD | 261 | A6NNM3 | |
| RSLGLVSSACSSSPD | 261 | A6NJZ7 | |
| SCPESAPFRLQGSSS | 136 | O75154 | |
| SPLLSPGCTSSSSAA | 751 | Q9ULD8 | |
| PGCTSSSSAAKLLSP | 756 | Q9ULD8 | |
| STSDSEPPASGDLCS | 996 | Q9ULD8 | |
| SSCDVSSSPSLPSRT | 496 | O75140 | |
| ASPGESARLTCTLPS | 31 | A0A075B6J1 | |
| LLCSSFRESTAGSPP | 316 | Q8NGN2 | |
| GARSTSPSDSLPCSL | 221 | Q9BXK1 | |
| LSQCPRTLATSGPSF | 301 | Q3ZCV2 | |
| SRQIPASTCSSSLFP | 216 | Q4ZG55 | |
| DASQGSDTRICPPSS | 141 | Q68DU8 | |
| NGDLCSPKRSPTSSA | 1236 | Q9ULD2 | |
| CRDLDSSLRPSSSPG | 176 | Q9BV99 | |
| TGTISAANSCPSSPR | 201 | Q01167 | |
| SATLTPSSTCPSLVD | 1626 | O60333 | |
| SSCSLPPSLTTSTLA | 651 | O75145 | |
| PPSCSSRAAEAAATT | 56 | Q0VG99 | |
| CSSGSSSRDSLREPP | 711 | Q5JU85 | |
| SSLSSCEVTPVGSPR | 11 | Q6KB66 | |
| SSARSADCSVPSPAL | 566 | O43439 | |
| ASPGATARLPCTLSS | 31 | A0A075B6I3 | |
| TSAGSVRCSPPETLA | 881 | O94915 | |
| SHLSPPLCRSLSSST | 311 | Q14005 | |
| LSSPENSGSGSCPSL | 206 | Q9Y2U5 | |
| RDPSCLSPASSLSSR | 166 | O95644 | |
| GLPSLSCRTSCSSRP | 6 | O76009 | |
| ASPCSSPKTGLSARL | 26 | O94806 | |
| LPASSTPSADSRPSC | 81 | Q8N3J3 | |
| SCTEGPLFSSPRSAV | 61 | P08151 | |
| TRSVSASSGPCSPAA | 346 | Q86UY5 | |
| ADSDSSSCRPGLPSF | 281 | Q8IXW0 | |
| CRSASGPTLSLPTEG | 606 | Q6UVM3 | |
| PSCAAAETGARTSLP | 106 | B2CW77 | |
| ERTESSCSRPSPDGL | 466 | Q9BZE0 | |
| GCTPLASAPTRSDSF | 771 | Q9Y5F7 | |
| CLFPRRSSASVSGSP | 406 | P35568 | |
| STRCPASEPGLDATT | 1026 | Q27J81 | |
| LASDSGCPPLSSTAV | 2636 | Q6V1P9 | |
| PSLTRFCSRSSLPTG | 351 | P0CG20 | |
| SSPAECSLELSPSRP | 1691 | Q96QU1 | |
| SPACASGRPSATVDS | 866 | A1KZ92 | |
| PSPISSSSSSCSRGG | 36 | Q92908 | |
| RSPLSTTLGTSPACG | 21 | Q494R0 | |
| GLVPSLSSSCVPDSS | 1471 | P49454 | |
| SCSASPSAVTAAGRP | 16 | Q9UKT4 | |
| CLRSPATPSDSSSFL | 446 | Q8NCQ5 | |
| SSSSSRPRSCEVPGI | 236 | Q53ET0 | |
| RSISTPTCLGGSPAA | 431 | O00257 | |
| LCSADAAVSTTPPGS | 1246 | Q9BTC0 | |
| FGLTPNRPSLSACSS | 1066 | Q9P203 | |
| ISSSCGSTPSASLGR | 346 | Q8TF61 | |
| TPNSRFSAPSCGSSE | 446 | Q03164 | |
| CCPSSSSSRPPTRTS | 131 | Q9H693 | |
| SSCNSSSLGPTRPTI | 691 | Q86VB7 | |
| SREGPPNSSAATLCS | 1491 | D6RIA3 | |
| PAFASSLTSCGPRAL | 46 | Q96EY1 | |
| LPCSSDSPASASRVA | 131 | Q96MD7 | |
| ASLPDSSLATSAPLC | 491 | Q7Z5L9 | |
| TRLPFSSSCSIPDCA | 2226 | Q8TDX9 | |
| GTDASPSSCGSLPIT | 531 | Q9BXL7 | |
| SRAARVPGPSSSLCA | 6 | P42830 | |
| PASRATSPLCTSTAS | 141 | P30622 | |
| CDSPLASALPRSSFS | 31 | Q96NU0 | |
| SISPLSDPLSTSSSC | 156 | P32243 | |
| DASPSSLCGLPASAT | 266 | Q9H0X9 | |
| SPSVDARPCSSPSEL | 16 | P00540 | |
| STPSESGICRFTASP | 1861 | O60469 | |
| LSSDESPRNPGCSGS | 231 | Q8N2Y8 | |
| GCSPDAPSLSGRSSA | 331 | Q06945 | |
| LNSASTSLPTSCPGS | 491 | Q9Y6A5 | |
| SLPESSVPSTVGCSS | 366 | Q494U1 | |
| PLLRCDSTSSGSSAL | 556 | O75509 | |
| RSLGLVSSACSSSPD | 261 | Q9UFD9 | |
| DPRLSCSSPSRGDPS | 546 | Q9Y2N7 | |
| PVTPGAASLCSFSSS | 181 | Q96CC6 | |
| LSSASCRPSLSPTSG | 41 | Q9H2Y9 | |
| TSRAPPCSGSSITEI | 896 | Q92835 | |
| TGSNLPRRSCPSSAA | 1331 | Q9C0A6 | |
| TRGSLTLCPSRSSNP | 296 | Q9NYZ4 | |
| AASCSPPRSAPSSDS | 136 | Q8IZD0 | |
| GDRSSSSSSLPCPAP | 61 | O15457 | |
| SCPGPLDSSAFLSSD | 361 | Q9NP71 | |
| PSFDSLGRCPLTSES | 136 | Q8WXE9 | |
| SSCGLPPSTASAVRR | 531 | Q96GD3 | |
| LLGVDFPDSSSPSCT | 146 | Q8TE77 | |
| PSLAGSSPRCGDASS | 421 | Q8IUL8 | |
| RPTDSCFSSSSDLPS | 486 | Q86WS4 | |
| SSPRSLLCSISGPGS | 41 | Q8NBR9 | |
| SGLGSPNRSSPSIIC | 161 | Q9NZN8 | |
| LCTTGSRPSSDSFPK | 1126 | O75443 | |
| SSLPSTTSCTALLPS | 671 | Q5T6F2 | |
| SRGCTSSSSLSPPRG | 11 | Q96LT9 | |
| ERASPPSSSCNISSG | 201 | P04275 | |
| RLSDPLLSTCSSGPL | 476 | O76050 | |
| LAAACASRALPPSSS | 306 | Q86UD0 | |
| SPPCSLLLDSSLSSN | 416 | Q99640 | |
| KPPGSLARSSSLCRS | 501 | Q9P246 | |
| DPSTLCSGDSSRPAL | 561 | Q13214 | |
| TCASSREPLGGLSSS | 386 | Q6ZMY3 | |
| NCLDLSPRSLSGSPS | 1096 | Q9BX26 | |
| LISPASTPSCLSAAS | 976 | O95271 | |
| SDSSSPSCSSGPRVP | 456 | Q92610 | |
| NUSSCLSLLRSTPAA | 126 | Q9NZV5 | |
| AAPGPSKRDSDCSSL | 476 | O94804 | |
| LTDSSSPGVGASCRP | 861 | O75044 | |
| NGSCADPSPSASLTA | 411 | Q7L0X0 | |
| CLSPPSSDGSLLDSP | 496 | Q9NQB0 | |
| SPTRSESPEPAATCS | 16 | Q9NS37 | |
| SSPSSSCPSAALGRR | 231 | Q17RH7 | |
| AVTLSCRSGLSPTPD | 526 | Q9BZZ2 | |
| DSGFLGTTPTLSCSL | 496 | Q15393 | |
| AGCDTSSTPSNTAPR | 16 | Q8IYB0 | |
| GRSLSSCSPQPTDSL | 356 | Q9UKP6 | |
| RSSIGTAPPDTSTCS | 1266 | Q7Z7G8 | |
| SSVAPDSTSGLRPCG | 186 | Q8N446 | |
| DDSSSRRCSAPGESP | 76 | Q9Y2P0 | |
| DTSAGNSSLLCFPRP | 181 | Q5T619 | |
| ALSSSPRCEPGFSSE | 181 | Q13342 | |
| SGSSPSSSSLCTEPL | 71 | Q9UMR3 | |
| PSNVPSCRSLSSSED | 16 | O15482 | |
| SCRSLSSSEDGPSGP | 21 | O15482 | |
| SPSSSSDCLVNRGGP | 741 | Q59H18 | |
| DAPCSASSELSGPST | 896 | Q63HR2 | |
| TSEPRSCSSISTALP | 771 | Q9P275 | |
| CVSRPDSGLPTTSLD | 46 | Q6ZQT7 | |
| SLSRPSSSCLPLASF | 186 | Q6ZQT7 | |
| LTSLCSSSSDPAPSD | 571 | Q9P206 | |
| SSSSSCISLPPVLSD | 141 | Q96HR8 | |
| TLAASCTAEGSPAPS | 166 | Q96NY8 |